Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Effect of Maternal Inflammation on Placental Transfer of Lopinavir and Ritonavir in Rats

FY 2016-17

Summary
HIV-positive women often receive antiretroviral medications during pregnancy to prevent transmission of the virus to the fetus. The fetus is typically prevented from exposure to these drugs by proteins in the placenta that actively remove foreign substances that attempt to enter the fetal compartment. Maternal inflammation, which commonly occurs in pregnancy, has been shown to decrease the expression of these placental proteins, which increases fetal exposure to drugs. The risk this poses to the fetus is both unknown and understudied. The proposed research aims to explore the effect of maternal inflammation on the disposition of a combination of antiretrovirals across the placenta in pregnant rats. Antiretroviral therapy typically involves administration of a combination of two or more medications to improve the concentration of medication absorbed into the maternal bloodstream. This implies that drug distribution into fetal tissues may consequently also be increased during maternal inflammation due to decreased protein expression of drug transporters. To study this, pregnant rats will be induced into a state of inflammation and then administered a combination of lopinavir and ritonavir, a common antiretroviral therapy. The concentrations of each drug in the maternal plasma, fetal tissue, and placenta will be measured and compared to a control group of rats that did not experience maternal inflammation. It is hoped that the knowledge gained from this study will aid in the understanding of drug transport across the placenta. Additionally, the results of this study could be used to improve the safety (of both the mother and the fetus) and efficacy of treatment of HIV-positive women during pregnancy.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367240
Name
McColl Eliza R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of Maternal Inflammation on Placental Transfer of Lopinavir and Ritonavir in Rats
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antiretrovirals; Drug Transport Proteins; Hiv; Pharmaceutical Science; Pharmacokinetics; Pharmacology; Pregnancy; Toxicity
Abstract
HIV-positive women often receive antiretroviral medications during pregnancy to prevent transmission of the virus to the fetus. The fetus is typically prevented from exposure to these drugs by proteins in the placenta that actively remove foreign substances that attempt to enter the fetal compartment. Maternal inflammation, which commonly occurs in pregnancy, has been shown to decrease the expression of these placental proteins, which increases fetal exposure to drugs. The risk this poses to the fetus is both unknown and understudied. The proposed research aims to explore the effect of maternal inflammation on the disposition of a combination of antiretrovirals across the placenta in pregnant rats. Antiretroviral therapy typically involves administration of a combination of two or more medications to improve the concentration of medication absorbed into the maternal bloodstream. This implies that drug distribution into fetal tissues may consequently also be increased during maternal inflammation due to decreased protein expression of drug transporters. To study this, pregnant rats will be induced into a state of inflammation and then administered a combination of lopinavir and ritonavir, a common antiretroviral therapy. The concentrations of each drug in the maternal plasma, fetal tissue, and placenta will be measured and compared to a control group of rats that did not experience maternal inflammation. It is hoped that the knowledge gained from this study will aid in the understanding of drug transport across the placenta. Additionally, the results of this study could be used to improve the safety (of both the mother and the fetus) and efficacy of treatment of HIV-positive women during pregnancy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
McColl, Eliza R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~